The NeuroCognitive & Behavioral Institute (formerly The NeuroCognitive Institute) is currently enrolling volunteers for the following clinical trials.
Past Studies
Pediatric/Neurodevelopmental Disorders
- D1AMOND Study, a Phase 2B Study to Evaluate the Efficacy and Safety of Ecopipam Tablets in Children and Adolescent Subjects with Tourette’s Syndrome
- A Randomized, Placebo-controlled Trial to Evaluate the Long-term Efficacy of Oral Aripiprazole in the Treatment of Pediatric Subjects With Tourette’s Disorder
- The T-Force Platinum Research Study
- A 12-Month Open-Label, Repeat-Dose Safety Study In Epilepsy Subjects
- A Phase 2b, Randomized, Double-Blind, Placebo-controlled, Dose Optimization Study to Assess the Safety, Tolerability and Efficacy of NBI-98854 for the Treatment of Pediatric Subjects with Tourette Syndrome.
- A Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Safety and
- Efficacy of Fixed-dose Once-daily Oral Aripiprazole in Children and Adolescents with Tourette’s Disorder. PI – 2012-2014
- Double Blind Phase IV trial on Patients with ADHD. PI – 2012 – 2013
- Open Label Phase IV trial on Patients with ADHD. PI – 2012-2013